High Purity 10-Hydroxycamptothecin API for Pharmaceutical Development and Cancer Research
A potent topoisomerase I inhibitor derived from nature, crucial for advancing cancer therapies.
Get a Quote & SampleProduct Core Value
10-Hydroxycamptothecin
10-Hydroxycamptothecin is a powerful camptothecin derivative, recognized for its significant anticancer properties as a topoisomerase I inhibitor. It stabilizes the DNA-topoisomerase I complex, leading to DNA damage and triggering apoptosis in cancer cells, making it a vital component in pharmaceutical development and cancer research.
- Discover the potential of 10-hydroxycamptothecin pharmaceutical grade in novel cancer treatment strategies.
- Source high-quality 10-hydroxycamptothecin for your critical research needs.
- Explore the mechanisms of topoisomerase I inhibitor powder in cellular processes.
- Investigate the anticancer efficacy of camptothecin derivatives for advanced therapies.
Advantages of Using 10-Hydroxycamptothecin
Potent Anticancer Activity
Leverage the power of 10-hydroxycamptothecin pharmaceutical grade to inhibit topoisomerase I, a key mechanism in combating cancer cell growth.
Natural Origin and Synthesis Potential
Benefit from a compound derived from the Camptotheca acuminata tree, with ongoing research in sustainable synthesis for pharmaceutical development.
Foundation for Drug Discovery
Utilize this API as a crucial building block for creating enhanced drug formulations and exploring synergistic effects in combination therapies, addressing complex medicinal chemistry challenges.
Key Applications
Cancer Treatment Research
The 10-hydroxycamptothecin supplier China can provide this compound for extensive research into its effectiveness against various cancers, including colorectal and ovarian cancers.
Pharmaceutical Development
Enhance drug formulation and bioavailability by using high-purity 10-hydroxycamptothecin, crucial for improving patient outcomes in cancer therapy.
Combination Therapy Studies
Investigate the synergistic effects of 10-hydroxycamptothecin with other chemotherapeutic agents to optimize treatment regimens and improve efficacy.
Mechanism of Action Studies
Use this topoisomerase I inhibitor powder as a model compound to study DNA damage and repair mechanisms, furthering our understanding of cellular responses to chemotherapy.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).